Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
In general, a missed dose can be administered as soon as remembered, unless it is almost time for the next dose
This interaction with the NO system is part of why BPC-157 appears in gut health research as well as musculoskeletal research
Tap the closest fit
Always consult with a qualified health care provider regarding a medical condition
Unlike oral supplements, injections bypass the digestive system, ensuring optimal absorption for those with deficiencies or difficulty absorbing B12 from food